Retigabine strongly reduces repetitive firing in rat entorhinal cortex

Citation
R. Hetka et al., Retigabine strongly reduces repetitive firing in rat entorhinal cortex, EUR J PHARM, 386(2-3), 1999, pp. 165-171
Citations number
36
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
386
Issue
2-3
Year of publication
1999
Pages
165 - 171
Database
ISI
SICI code
0014-2999(199912)386:2-3<165:RSRRFI>2.0.ZU;2-2
Abstract
Retigabine (D-23129) [N-(2-amino-3-(4-fluorobenzylamino)phenyl) carbamic ac id ethyl ester] is a novel antiepileptic drug. The compound was shown to po ssess anticonvulsant properties both in vivo and in vitro. We investigated the effects of retigabine on neurones in the rat medial entorhinal cortex u sing conventional intracellular recordings in combined hippocampal-entorhin al cortex slices. Retigabine strongly reduced the number of action potentia ls elicited by 1 s long depolarising current injections. Both the amplitude s of monosynaptic inhibitory postsynaptic potentials/currents (IPSP/Cs) and the amplitudes of excitatory postsynaptic potentials (EPSPs) remained unaf fected. The drug increased outward rectification and induced a membrane-pot ential hyperpolarisation in most of the tested neurones. The findings sugge st that retigabine exerts its anticonvulsant effects by activation of a Kconductance, however it cannot be excluded from our experiments that other mechanisms may be involved in the effect of retigabine on membrane properti es. (C) 1999 Elsevier Science B.V. All rights reserved.